The American Medical Association criticizes Biden’s test-to-treat COVID program. Healthcare employment jumped in February, yet it’s still below pre-pandemic levels. And Civica announces plans to manufacture low-cost insulin.
Hosted on Acast. See acast.com/privacy for more information.
